drugset / Trial / NCT06279923
CD19-BAFF CAR-T Cells Therapy for Patients With Autoimmune Diseases
NaSingle-groupOpen-labelTreatment
Summary
Clinical Trial for the safety and efficacy of CD19-BAFF CAR-T cells therapy for Autoimmune Diseases.
Timeline
- Start
- 2024-04-15
- Primary completion
- 2027-02-01
- Completion
- 2027-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CD19-BAFF Targeted CAR T-cells | Cell therapy | — | Intravenous |